Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-10-18
1992-07-07
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514328, 546219, 546220, 546242, A61K 31445, C07D21146
Patent
active
051283476
ABSTRACT:
Novel compounds represented by the formula: ##STR1## wherein R represents hydrogen, alkyl radicals having from 1 to about 10 carbon atoms, alkenyl radicals having from 1 to about 10 carbon atoms, aryl, alkaryl and aralkyl radicals having from about 6 to about 16 carbon atoms and acyl and acyloxy radicals having from about 1 to about 10 carbon atoms, manifest glycosidase inhibition activity.
REFERENCES:
patent: 5025021 (1991-06-01), Getman et al.
patent: 5026713 (1991-06-01), Getman et al.
Heiker et al., "Synthesis of D-Galacto-1-Deoxynojirimycin (1,5-dideoxy-1,5-imino-D-galactitol) Starting From 1-Deoxynojirimycin", Carbohydrate Research,203,314-318 (1990).
Schueller et al., "Synthesis of 2-Acetamido-1,2-Dideoxy-D-Galactonojirimycin (2-acetamido-1,2,5-trideoxy-1 ,5-imino-D-galactitol) From 1-Deoxynojirimycin, "Carbohydrate Research, 203,308-313 (1990).
DeCrescenzo Gary A.
Getman Daniel P.
Bolding James C.
Dentz Bernard
Goetz Kenneth D.
Monsanto Company
Passley Paul L.
LandOfFree
Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1830000